Click for best price
Antipyretic Analgesics Market Size, Share 2024
| Market size in 2023 |
US$ 2862.1 million
|
Forecast Market size by 2030 |
US$ 3100.3 million
|
| Growth Rate |
CAGR of 1.1% |
Number of Pages |
60 Pages |
The global Antipyretic Analgesics market was valued at US$ 2862.1 million in 2023 and is projected to reach US$ 3100.3 million by 2030, at a CAGR of 1.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesics. This report contains market size and forecasts of Antipyretic Analgesics in global, including the following market information:
- Global Antipyretic Analgesics Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.
We surveyed the Antipyretic Analgesics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antipyretic Analgesics Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Antipyretic Analgesics Market Segment Percentages, by Type, 2023 (%)
- Paracetamol
- Aspirin
- Ibuprofen
- Noproxen
- Diclofenac
- Others
Global Antipyretic Analgesics Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Antipyretic Analgesics Market Segment Percentages, by Application, 2023 (%)
Global Antipyretic Analgesics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Antipyretic Analgesics Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Antipyretic Analgesics revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Antipyretic Analgesics revenues share in global market, 2023 (%)
key players include:
- Bayer
- Actavis
- Mylan
- Pfizer
- Novartis
- Horizon Pharma
- Iroko Pharmaceuticals
- Hoechst
- Xinhua Pharm
- Teva
- Hebei Jiheng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antipyretic Analgesics, market overview.
Chapter 2: Global Antipyretic Analgesics market size in revenue.
Chapter 3: Detailed analysis of Antipyretic Analgesics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antipyretic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antipyretic Analgesics Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 2862.1 million
|
| Forecast Market size by 2030 |
US$ 3100.3 million
|
| Growth Rate |
CAGR of 1.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antipyretic Analgesics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antipyretic Analgesics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antipyretic Analgesics Overall Market Size
2.1 Global Antipyretic Analgesics Market Size: 2023 VS 2030
2.2 Global Antipyretic Analgesics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antipyretic Analgesics Players in Global Market
3.2 Top Global Antipyretic Analgesics Companies Ranked by Revenue
3.3 Global Antipyretic Analgesics Revenue by Companies
3.4 Top 3 and Top 5 Antipyretic Analgesics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Antipyretic Analgesics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antipyretic Analgesics Players in Global Market
3.6.1 List of Global Tier 1 Antipyretic Analgesics Companies
3.6.2 List of Global Tier 2 and Tier 3 Antipyretic Analgesics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antipyretic Analgesics Market Size Markets, 2023 & 2030
4.1.2 Paracetamol
4.1.3 Aspirin
4.1.4 Ibuprofen
4.1.5 Noproxen
4.1.6 Diclofenac
4.1.7 Others
4.2 By Type - Global Antipyretic Analgesics Revenue & Forecasts
4.2.1 By Type - Global Antipyretic Analgesics Revenue, 2019-2024
4.2.2 By Type - Global Antipyretic Analgesics Revenue, 2025-2030
4.2.3 By Type - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antipyretic Analgesics Market Size, 2023 & 2030
5.1.2 Adult
5.1.3 Child
5.2 By Application - Global Antipyretic Analgesics Revenue & Forecasts
5.2.1 By Application - Global Antipyretic Analgesics Revenue, 2019-2024
5.2.2 By Application - Global Antipyretic Analgesics Revenue, 2025-2030
5.2.3 By Application - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Antipyretic Analgesics Market Size, 2023 & 2030
6.2 By Region - Global Antipyretic Analgesics Revenue & Forecasts
6.2.1 By Region - Global Antipyretic Analgesics Revenue, 2019-2024
6.2.2 By Region - Global Antipyretic Analgesics Revenue, 2025-2030
6.2.3 By Region - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Antipyretic Analgesics Revenue, 2019-2030
6.3.2 US Antipyretic Analgesics Market Size, 2019-2030
6.3.3 Canada Antipyretic Analgesics Market Size, 2019-2030
6.3.4 Mexico Antipyretic Analgesics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Antipyretic Analgesics Revenue, 2019-2030
6.4.2 Germany Antipyretic Analgesics Market Size, 2019-2030
6.4.3 France Antipyretic Analgesics Market Size, 2019-2030
6.4.4 U.K. Antipyretic Analgesics Market Size, 2019-2030
6.4.5 Italy Antipyretic Analgesics Market Size, 2019-2030
6.4.6 Russia Antipyretic Analgesics Market Size, 2019-2030
6.4.7 Nordic Countries Antipyretic Analgesics Market Size, 2019-2030
6.4.8 Benelux Antipyretic Analgesics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Antipyretic Analgesics Revenue, 2019-2030
6.5.2 China Antipyretic Analgesics Market Size, 2019-2030
6.5.3 Japan Antipyretic Analgesics Market Size, 2019-2030
6.5.4 South Korea Antipyretic Analgesics Market Size, 2019-2030
6.5.5 Southeast Asia Antipyretic Analgesics Market Size, 2019-2030
6.5.6 India Antipyretic Analgesics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Antipyretic Analgesics Revenue, 2019-2030
6.6.2 Brazil Antipyretic Analgesics Market Size, 2019-2030
6.6.3 Argentina Antipyretic Analgesics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antipyretic Analgesics Revenue, 2019-2030
6.7.2 Turkey Antipyretic Analgesics Market Size, 2019-2030
6.7.3 Israel Antipyretic Analgesics Market Size, 2019-2030
6.7.4 Saudi Arabia Antipyretic Analgesics Market Size, 2019-2030
6.7.5 UAE Antipyretic Analgesics Market Size, 2019-2030
7 Antipyretic Analgesics Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Antipyretic Analgesics Major Product Offerings
7.1.4 Bayer Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.1.5 Bayer Key News & Latest Developments
7.2 Actavis
7.2.1 Actavis Company Summary
7.2.2 Actavis Business Overview
7.2.3 Actavis Antipyretic Analgesics Major Product Offerings
7.2.4 Actavis Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.2.5 Actavis Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Antipyretic Analgesics Major Product Offerings
7.3.4 Mylan Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.3.5 Mylan Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Antipyretic Analgesics Major Product Offerings
7.4.4 Pfizer Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Antipyretic Analgesics Major Product Offerings
7.5.4 Novartis Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.5.5 Novartis Key News & Latest Developments
7.6 Horizon Pharma
7.6.1 Horizon Pharma Company Summary
7.6.2 Horizon Pharma Business Overview
7.6.3 Horizon Pharma Antipyretic Analgesics Major Product Offerings
7.6.4 Horizon Pharma Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.6.5 Horizon Pharma Key News & Latest Developments
7.7 Iroko Pharmaceuticals
7.7.1 Iroko Pharmaceuticals Company Summary
7.7.2 Iroko Pharmaceuticals Business Overview
7.7.3 Iroko Pharmaceuticals Antipyretic Analgesics Major Product Offerings
7.7.4 Iroko Pharmaceuticals Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.7.5 Iroko Pharmaceuticals Key News & Latest Developments
7.8 Hoechst
7.8.1 Hoechst Company Summary
7.8.2 Hoechst Business Overview
7.8.3 Hoechst Antipyretic Analgesics Major Product Offerings
7.8.4 Hoechst Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.8.5 Hoechst Key News & Latest Developments
7.9 Xinhua Pharm
7.9.1 Xinhua Pharm Company Summary
7.9.2 Xinhua Pharm Business Overview
7.9.3 Xinhua Pharm Antipyretic Analgesics Major Product Offerings
7.9.4 Xinhua Pharm Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.9.5 Xinhua Pharm Key News & Latest Developments
7.10 Teva
7.10.1 Teva Company Summary
7.10.2 Teva Business Overview
7.10.3 Teva Antipyretic Analgesics Major Product Offerings
7.10.4 Teva Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.10.5 Teva Key News & Latest Developments
7.11 Hebei Jiheng
7.11.1 Hebei Jiheng Company Summary
7.11.2 Hebei Jiheng Business Overview
7.11.3 Hebei Jiheng Antipyretic Analgesics Major Product Offerings
7.11.4 Hebei Jiheng Antipyretic Analgesics Revenue in Global Market (2019-2024)
7.11.5 Hebei Jiheng Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antipyretic Analgesics Market Opportunities & Trends in Global Market
Table 2. Antipyretic Analgesics Market Drivers in Global Market
Table 3. Antipyretic Analgesics Market Restraints in Global Market
Table 4. Key Players of Antipyretic Analgesics in Global Market
Table 5. Top Antipyretic Analgesics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Antipyretic Analgesics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Antipyretic Analgesics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Antipyretic Analgesics Product Type
Table 9. List of Global Tier 1 Antipyretic Analgesics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antipyretic Analgesics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Antipyretic Analgesics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Antipyretic Analgesics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Antipyretic Analgesics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Antipyretic Analgesics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Antipyretic Analgesics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Antipyretic Analgesics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Antipyretic Analgesics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Antipyretic Analgesics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Antipyretic Analgesics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Antipyretic Analgesics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Antipyretic Analgesics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Antipyretic Analgesics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Antipyretic Analgesics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Antipyretic Analgesics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Antipyretic Analgesics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Antipyretic Analgesics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Antipyretic Analgesics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Antipyretic Analgesics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Antipyretic Analgesics Revenue, (US$, Mn), 2025-2030
Table 30. Bayer Company Summary
Table 31. Bayer Antipyretic Analgesics Product Offerings
Table 32. Bayer Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 33. Bayer Key News & Latest Developments
Table 34. Actavis Company Summary
Table 35. Actavis Antipyretic Analgesics Product Offerings
Table 36. Actavis Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 37. Actavis Key News & Latest Developments
Table 38. Mylan Company Summary
Table 39. Mylan Antipyretic Analgesics Product Offerings
Table 40. Mylan Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 41. Mylan Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Antipyretic Analgesics Product Offerings
Table 44. Pfizer Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Antipyretic Analgesics Product Offerings
Table 48. Novartis Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 49. Novartis Key News & Latest Developments
Table 50. Horizon Pharma Company Summary
Table 51. Horizon Pharma Antipyretic Analgesics Product Offerings
Table 52. Horizon Pharma Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 53. Horizon Pharma Key News & Latest Developments
Table 54. Iroko Pharmaceuticals Company Summary
Table 55. Iroko Pharmaceuticals Antipyretic Analgesics Product Offerings
Table 56. Iroko Pharmaceuticals Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 57. Iroko Pharmaceuticals Key News & Latest Developments
Table 58. Hoechst Company Summary
Table 59. Hoechst Antipyretic Analgesics Product Offerings
Table 60. Hoechst Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 61. Hoechst Key News & Latest Developments
Table 62. Xinhua Pharm Company Summary
Table 63. Xinhua Pharm Antipyretic Analgesics Product Offerings
Table 64. Xinhua Pharm Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 65. Xinhua Pharm Key News & Latest Developments
Table 66. Teva Company Summary
Table 67. Teva Antipyretic Analgesics Product Offerings
Table 68. Teva Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 69. Teva Key News & Latest Developments
Table 70. Hebei Jiheng Company Summary
Table 71. Hebei Jiheng Antipyretic Analgesics Product Offerings
Table 72. Hebei Jiheng Antipyretic Analgesics Revenue (US$, Mn) & (2019-2024)
Table 73. Hebei Jiheng Key News & Latest Developments
List of Figures
Figure 1. Antipyretic Analgesics Segment by Type in 2023
Figure 2. Antipyretic Analgesics Segment by Application in 2023
Figure 3. Global Antipyretic Analgesics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Antipyretic Analgesics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Antipyretic Analgesics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antipyretic Analgesics Revenue in 2023
Figure 8. By Type - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Antipyretic Analgesics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Antipyretic Analgesics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 16. US Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 20. Germany Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 21. France Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 28. China Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 32. India Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 34. Brazil Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Antipyretic Analgesics Revenue Market Share, 2019-2030
Figure 37. Turkey Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Antipyretic Analgesics Revenue, (US$, Mn), 2019-2030
Figure 41. Bayer Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Actavis Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Mylan Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pfizer Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Novartis Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Horizon Pharma Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Iroko Pharmaceuticals Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Hoechst Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Xinhua Pharm Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Teva Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Hebei Jiheng Antipyretic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
